Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityGRIF / Griffin Industrial Realty, Inc. (398231100)
President and CEOGamzon Michael
IndustryReal Estate
Institutional Owners38
Institutional Shares2,461,706 - 48.95%
Common Shares Outstanding5,028,608 shares (as of 2018-05-31)
Institutional Value$ 95,123,000 USD

Institutional Stock Ownership and Shareholders()

GRIF / Griffin Industrial Realty, Inc.  Institutional Ownership

Griffin Industrial Realty, Inc. (NASDAQ:GRIF) has 38 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,461,706 shares. Largest shareholders include Gamco Investors, Inc. Et Al, Gabelli Funds Llc, Teton Advisors, Inc., Dimensional Fund Advisors Lp, Franklin Resources Inc, BlackRock Inc., Vanguard Group Inc, BlackRock Institutional Trust Company, N.A., Towerview Llc, and Royce & Associates LLC.
Griffin Industrial Realty, Inc. (NASDAQ:GRIF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/grif"><img src="https://images.fintel.io/us-grif-so.png" alt="GRIF / Griffin Industrial Realty, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR Bank of New York Mellon Corp 9,700 10,664 9.94 356 400 12.36
2018-05-09 13F-HR GAMCO INVESTORS, INC. ET AL 841,534 837,113 -0.53 30,884 31,417 1.73
2018-05-14 13F-HR Royce & Associates LLC 38,784 34,784 -10.31 1,423 1,305 -8.29
2018-05-14 13F-HR Renaissance Technologies LLC 23,300 23,300 0.00 855 874 2.22
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 1,446 0 -100.00 53 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 0 1 0 0
2018-05-15 13F-HR DEUTSCHE BANK AG\ 8,408 6,188 -26.40 307 230 -25.08
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 205,609 205,911 0.15 7,546 7,728 2.41
2018-05-15 13F-HR STATE STREET CORP 6,018 6,318 4.99 222 238 7.21
2018-05-09 13F-HR BlackRock Inc. 100,168 98,380 -1.79 3,676 3,692 0.44
2018-05-09 13F-HR Teton Advisors, Inc. 255,647 255,647 0.00 9,382 9,594 2.26
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 67,387 67,387 0.00 2,135 2,138 0.14
2018-05-11 13F-HR SEI INVESTMENTS CO 6 0
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 1,188 1,188 0.00 44 45 2.27
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 55 55 0.00 2 2 0.00
2018-05-15 13F-HR BARCLAYS PLC 111 150 35.14 4 5 25.00
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 6 0 0
2018-05-14 13F-HR TEACHERS ADVISORS INC 765 0 -100.00 28 0 -100.00
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 495 0 -100.00 18 0 -100.00
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 468 444 -5.13 17 17 0.00
2018-05-11 13F-HR CITIGROUP INC 1,790 520 -70.95 65 19 -70.77
2017-02-10 13F-HR BlackRock Investment Management, LLC 705 705 0.00 22 22 0.00
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 126 0 -100.00 5 0 -100.00
2018-07-20 13F-HR WHITTIER TRUST CO 100 0 -100.00 4 0 -100.00
2018-05-10 13F-HR FRANKLIN RESOURCES INC 122,000 122,000 0.00 4,477 4,579 2.28
2018-05-10 13F-HR JP Morgan Chase & Co 150 150 0.00 6 6 0.00
2018-05-15 13F-HR VANGUARD GROUP INC 66,585 71,855 7.91 2,444 2,697 10.35
2018-05-09 13F-HR NORTHERN TRUST CORP 24,322 24,490 0.69 893 920 3.02
2017-02-10 13F-HR BlackRock Fund Advisors 23,440 27,376 16.79 743 869 16.96
2018-05-17 13F-HR Legal & General Group Plc 115 115 0.00 4 4 0.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 110 809 635.45 4 30 650.00
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 164 88 -46.34 6,019 3,303 -45.12
2018-05-14 13F-HR MORGAN STANLEY 1,550 1,641 5.87 57 62 8.77
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 10 0
2018-04-25 13F-HR TOWERVIEW LLC 52,939 48,827 -7.77 1,943 1,832 -5.71
2018-05-09 13F-HR GABELLI FUNDS LLC 570,550 569,550 -0.18 20,939 21,375 2.08
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 680 73 -89.26 21 3 -85.71
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 3,876 3,845 -0.80 142 144 1.41
2018-05-15 13F-HR UBS Group AG 412 0 -100.00 15 0 -100.00
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 100 100 0.00 4 4 0.00
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 12,065 12,149 0.70 442 455 2.94
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 18,205 18,205 0.00 668 683 2.25
2017-02-10 13F-HR BlackRock Advisors LLC 1,073 1,073 0.00 34 34 0.00
2018-05-10 13F-HR KINGS POINT CAPITAL MANAGEMENT 10,583 10,583 0.00 388 397 2.32

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 398231100